Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT - A pooled analysis of two randomized trials

European Radiology

Volumn 19, Issue 4, 2009, Pages 891-897

  Thomsen, Henrik S ^a   Morcos, Sameh K ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Computed tomography; Contrast medium induced nephropathy; High risk patients; Iodixanol; Iomeprol; Iopamidol

Indexed keywords

CREATININE; IODIXANOL; IOMEPROL; IOPAMIDOL; CONTRAST MEDIUM; IODOBENZOIC ACID DERIVATIVE;

AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OSMOLALITY; PRIORITY JOURNAL; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPUTER ASSISTED TOMOGRAPHY; DIMERIZATION; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK; TOXICITY;

AGED; CONTRAST MEDIA; DIMERIZATION; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, INTRAVENOUS; IOPAMIDOL; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 62649137038     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1206-4     Document Type: Article

References (29)

1. Barrett B, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379-386
2. Solomon R, Barrett B (2006) Follow-up of patients with contrast-induced nephropathy. Kidney Int 69:S46-S50
3. Thomsen HS, Morcos SK (2006) ESUR guidelines on contrast media. Abdom Imaging 31:131-140
4. Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int 69:S11-S15
5. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm, accessed March 6, 2008
6. Finn W (2006) The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 21:i2-i10
7. Thomsen HS (2007) ESUR guideline: Gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 17:2692-2696
8. Kanal E, Barkovich AJ, Bell C et al (2007) ACR Guidance Document for Safe MR Practices. AJR Am J Roentgenol 188:1-27
9. Thomsen HS, Marckmann P, Logager VB (2007) Enhanced computed tomography or magnetic resonance imaging: A choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis? Acta Radiol 48:593-596
10. Grobner T (2006) Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108
11. Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: Suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359-2362
12. Khurana A, Runge VM, Narayanan M et al (2007) Nephrogenic systemic fibrosis: A review of six cases temporally related to gadodiamide injection (Omniscan). Invest Radiol 42:139-145
13. Broome DR, Girguis MS, Baron PW et al (2007) Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned. Am J Roentgenol 188:586-592
14. Sadowski EA, Bennett LK, Chan MR et al (2007) Nephrogenic Systemic Fibrosis: Risk factors and incidence estimation. Radiology 243:148-157
15. Rydahl C, Thomsen HS, Marckmann P (2008) High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol 43:141-144
16. Thomsen HS, Marckmann P, Logager VB (2007) Nephrogenic systemic fibrosis (NSF): A late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 7:130-137
17. Thomsen HS (2008) Nephrogenic systemic fibrosis. Imaging Decis MRI 11:13-18
18. Prasad SR, Jarirdar J (2008) Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: A primer for radiologists. J Comput Assist Tomogr 32:1-3
19. Katzberg RW, Barrett BJ (2007) Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243:622-628
20. Barrett B, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography A double-blind comparison of iodixanol and iopamidol. Invest Radiol 41:815-821
21. Thomsen HS, Morcos SK, Erley CM et al (2008) The ACTIVE trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43:170-178
22. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-70
23. Hosmer DW, Lemeshow S (1980) Goodness of fit tests for the multiple logistic regression model. Commun Stat - Theory Meth A9:1043-1069
24. Carraro M, Malalan F, Antonione R et al (1998) Effects of a dimeric vs. a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: A double-blind, randomized clinical trial. Eur Radiol 8:144-147
25. Kolehmainen H, Soiva M (2003) Comparison of Xenetix 300 and Visipaque 320 in patients with renal failure. Eur Radiol 13:B32-B33
26. Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: The wheel has turned 360 degrees. Acta Radiol 49:646-657
27. Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock R, Berg KJ for the NEPHRIC Investigators (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499
28. Jo S-H, Youn T-J, Koo B-K et al (2006) Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabric (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: A randomized controlled trial. J Am Coll Cardiol 48:924-930
29. Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study. randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115:3189-3196